Stocks Health care IVA

NASDAQ · Health care

Inventiva S.A. (IVA)

It posted a net loss of $49.6M. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 8, 2026.

Watch IVA in 60 seconds

What Inventiva S.A. does

Inventiva S.A. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IVA.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Inventiva S.A. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 3, 2026
   Foreign issuer update 6-K
2. September 1, 2026
   Foreign issuer update 6-K
3. July 30, 2026
   Foreign issuer update (amended) 6-K/A
4. July 29, 2026
   Foreign issuer update 6-K
5. July 9, 2026
   Foreign issuer update 6-K
6. July 6, 2026
   Foreign issuer update 6-K
7. June 12, 2026
   Foreign issuer update 6-K
8. June 12, 2026
   Foreign issuer update 6-K
9. June 9, 2026
   Foreign issuer update 6-K
10. June 3, 2026
    Foreign issuer update 6-K

Insider trades

What the people running Inventiva S.A. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns IVA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Deep Track Capital, LP 3.76% (May 15, 2026); New Enterprise Associates 17, L.P. 4.9% (April 1, 2026); Great Point Partners, LLC 3.49% (February 17, 2026); Eventide Asset Management, LLC 4.6% (February 13, 2026); Bvf Partners L P 4.99% (November 19, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about IVA

What does Inventiva S.A. do?

Inventiva S.A. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IVA.

Is Inventiva S.A. profitable?

No. In fiscal 2021 it reported a net loss of $49.6M.

When did Inventiva S.A. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 8, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 3, 2026.

Similar companies

Compare IVA with

Compare IVA with any company

Follow IVA

Get an email when Inventiva S.A. files with the SEC: results, executive changes, material agreements and annual reports.

Follow IVA: get an email when it files

Where the numbers come from

Financial figures are the values Inventiva S.A. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.